Search filters

List of works by Suleiman Massarweh

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

scientific article published on July 27, 2011

Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.

scientific article

Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer

scientific article

Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts

scientific article published on September 2008

ErbB3 downregulation enhances luminal breast tumor response to antiestrogens

scientific article published on 03 September 2013

Everolimus-induced hematologic changes in patients with metastatic breast cancer

scientific article

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer

scientific article published on December 2014

Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts

scientific article published on December 7, 2010

Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk

scientific article published on December 2006

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

scientific article

Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities

scientific article published on April 2007

Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies

scientific article published on May 29, 2012